0.3138
price up icon2.90%   0.00885
after-market 시간 외 거래: .30 -0.0138 -4.40%
loading
전일 마감가:
$0.305
열려 있는:
$0.3074
하루 거래량:
100.74K
Relative Volume:
0.03
시가총액:
$3.52M
수익:
$1.75M
순이익/손실:
$-5.68M
주가수익비율:
-0.0644
EPS:
-4.8726
순현금흐름:
-
1주 성능:
+2.05%
1개월 성능:
+12.55%
6개월 성능:
+46.46%
1년 성능:
-70.11%
1일 변동 폭
Value
$0.30
$0.3173
1주일 범위
Value
$0.297
$0.3195
52주 변동 폭
Value
$0.197
$1.79

Scisparc Ltd Stock (SPRC) Company Profile

Name
명칭
Scisparc Ltd
Name
전화
-
Name
주소
-
Name
직원
2
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
SPRC's Discussions on Twitter

SPRC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
SPRC
Scisparc Ltd
0.3138 3.45M 1.75M -5.68M 0 -4.8726
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Scisparc Ltd 주식(SPRC)의 최신 뉴스

pulisher
May 28, 2025

SciSparc announces publication of Japanese patent application - MSN

May 28, 2025
pulisher
May 27, 2025

SciSparc Unveils Japanese Patent for Novel Pain Relief Combination - TipRanks

May 27, 2025
pulisher
May 27, 2025

SciSparc secures Japanese patent for pain relief combo By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

SciSparc Ltd. Announces Publication of Japanese Patent Application - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

SciSparc secures Japanese patent for pain relief combo - Investing.com

May 27, 2025
pulisher
May 27, 2025

SciSparc Ltd. Announces Publication of Novel Japanese Patent for Enhanced Pain Management Therapy Combining Paracetamol and PEA - Nasdaq

May 27, 2025
pulisher
May 27, 2025

SciSparc Announces Publication of Japanese Patent Application - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

SciSparc's New Pain Relief Patent Could Make Paracetamol Safer for Millions - Stock Titan

May 27, 2025
pulisher
May 21, 2025

SciSparc sets annual shareholder meeting for June 25 By Investing.com - Investing.com Nigeria

May 21, 2025
pulisher
May 21, 2025

SciSparc sets annual shareholder meeting for June 25 - Investing.com Australia

May 21, 2025
pulisher
May 21, 2025

SciSparc Ltd. Announces Annual General Meeting for June 2025 - TipRanks

May 21, 2025
pulisher
May 13, 2025

SciSparc and Clearmind Secure European Patent for Cocaine Addiction Therapy - TipRanks

May 13, 2025
pulisher
May 12, 2025

SciSparc Ltd. Announces European Patent Application for Cocaine Addiction Treatment in Collaboration with Clearmind Medicine Inc. - Nasdaq

May 12, 2025
pulisher
May 12, 2025

SciSparc-Clearmind Collaboration Leads to Publication of - GlobeNewswire

May 12, 2025
pulisher
May 12, 2025

SciSparc-Clearmind Collaboration Leads to Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction - Stock Titan

May 12, 2025
pulisher
May 03, 2025

Aegis Capital Corp. acted as Exclusive Placement Agent on a $5.0 Million Private Placement for SciSparc Ltd. (NASDAQ: SPRC) - The Globe and Mail

May 03, 2025
pulisher
May 02, 2025

SciSparc Ltd: Weathering Stock Market Storms with 3.17M Market Cap - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

A review of SPRC’s current quarter earnings predictions - uspostnews.com

May 02, 2025
pulisher
Apr 30, 2025

What's Going On With jeffs' Brands Today? - Benzinga

Apr 30, 2025
pulisher
Apr 30, 2025

Jeffs' Brands to Sell Smart Repair Pro Unit, SciSparc Nutraceuticals Stake to Plantify Foods; Shares Jump - marketscreener.com

Apr 30, 2025
pulisher
Apr 25, 2025

SciSparc and Clearmind file patent for eating disorder treatment - Investing.com

Apr 25, 2025
pulisher
Apr 25, 2025

SciSparc and Clearmind file patent for eating disorder treatment By Investing.com - Investing.com India

Apr 25, 2025
pulisher
Apr 25, 2025

SciSparc announces collaboration with Clearmind Medicine - TipRanks

Apr 25, 2025
pulisher
Apr 25, 2025

SciSparc and Clearmind File Patent for Eating Disorder Treatment - TipRanks

Apr 25, 2025
pulisher
Apr 25, 2025

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders - The Manila Times

Apr 25, 2025
pulisher
Apr 25, 2025

SciSparc-Clearmind Collaboration Leads to Filing of - GlobeNewswire

Apr 25, 2025
pulisher
Apr 25, 2025

Novel Eating Disorder Treatment Patent Filed for 70M Patient Market | SPRC Stock News - Stock Titan

Apr 25, 2025
pulisher
Apr 25, 2025

3 Reasons OMI is Risky and 1 Stock to Buy Instead - The Globe and Mail

Apr 25, 2025
pulisher
Apr 18, 2025

Thinking Of Selling SciSparc Ltd (NASDAQ: SPRC) Stock? Check This Out First - Stocksregister

Apr 18, 2025
pulisher
Apr 17, 2025

SciSparc (NASDAQ:SPRC) Shares Down 6% – Here’s Why - Defense World

Apr 17, 2025
pulisher
Apr 01, 2025

SciSparc Extends Deadline for Miza III Ventures Deal - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

SciSparc Ltd. Extends Merger Agreement with AutoMax Motors - TipRanks

Apr 01, 2025
pulisher
Mar 27, 2025

SciSparc Ltd. (NASDAQ:SPRC) Short Interest Up 1,435.0% in March - Defense World

Mar 27, 2025
pulisher
Mar 25, 2025

SciSparc announces resale of 61.21M shares by selling shareholders; shares down - MSN

Mar 25, 2025
pulisher
Mar 21, 2025

SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement - Louisiana First News

Mar 21, 2025
pulisher
Mar 11, 2025

SciSparc and Clearmind Advance Cocaine Addiction Treatment with South Korean Patent Application - TipRanks

Mar 11, 2025
pulisher
Mar 10, 2025

Is the SciSparc Ltd (NASDAQ:SPRC) stock an investment opportunity? - US Post News

Mar 10, 2025
pulisher
Mar 10, 2025

SciSparc Shares Are Soaring Monday: What's Going On? - Benzinga

Mar 10, 2025
pulisher
Mar 10, 2025

Scisparc, Clearmind apply for patent in South Korea for its co-developed treatment to overcome cocaine addiction - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

SciSparc announces publication of patent via Clearmind collaboration - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

SciSparc-Clearmind Collaboration Leads to Publication of Patent Application for Cocaine Addiction Psychedelic Combination Treatment in South Korea - The Manila Times

Mar 10, 2025
pulisher
Mar 10, 2025

SciSparc Ltd. and Clearmind Medicine Inc. Announce Patent Application for Combination Treatment of Cocaine Addiction - Nasdaq

Mar 10, 2025
pulisher
Mar 10, 2025

Clearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South Korea - The Manila Times

Mar 10, 2025
pulisher
Mar 06, 2025

SciSparc Extends $2 Million Loan to Support Automax?s Growth Following Automax?s Entry into Direct Import of JAC Electric Vehicles - Marketscreener.com

Mar 06, 2025
pulisher
Mar 05, 2025

SciSparc Ltd. Agrees to Sell MitoCareX to N2OFF - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

SciSparc signs definitive agreement to sell MitoCareX to N2OFF - TipRanks

Mar 05, 2025
pulisher
Mar 03, 2025

SciSparc to sell MitoCareX to N2Off for $700,000 - MSN

Mar 03, 2025
pulisher
Mar 03, 2025

SciSparc divests MitoCareX stake for $700,000 and stock swa By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Mar 03, 2025

SciSparc divests MitoCareX stake for $700,000 and stock swa - Investing.com

Mar 03, 2025
pulisher
Mar 03, 2025

SciSparc Ltd. Announces Sale of MitoCareX Shares to N2Off for $700,000 and Stock Exchange Agreement - Nasdaq

Mar 03, 2025

Scisparc Ltd (SPRC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
자본화:     |  볼륨(24시간):